BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 17367606)

  • 1. Fibrolamellar carcinomas show overexpression of genes in the RAS, MAPK, PIK3, and xenobiotic degradation pathways.
    Kannangai R; Vivekanandan P; Martinez-Murillo F; Choti M; Torbenson M
    Hum Pathol; 2007 Apr; 38(4):639-44. PubMed ID: 17367606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expression of c-myc and c-N-ras in human cirrhotic livers, hepatocellular carcinomas and liver tissue surrounding the tumors.
    Zhang XK; Huang DP; Qiu DK; Chiu JF
    Oncogene; 1990 Jun; 5(6):909-14. PubMed ID: 2163054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ras oncogene p21 expression in hepatocellular carcinoma.
    Jagirdar J; Nonomura A; Patil J; Thor A; Paronetto F
    J Exp Pathol; 1989; 4(1):37-46. PubMed ID: 2550600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytogenetic aberrations in primary and recurrent fibrolamellar hepatocellular carcinoma detected by comparative genomic hybridization.
    Wilkens L; Bredt M; Flemming P; Kubicka S; Klempnauer J; Kreipe H
    Am J Clin Pathol; 2000 Dec; 114(6):867-74. PubMed ID: 11338475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Met-regulated expression signature defines a subset of human hepatocellular carcinomas with poor prognosis and aggressive phenotype.
    Kaposi-Novak P; Lee JS; Gòmez-Quiroz L; Coulouarn C; Factor VM; Thorgeirsson SS
    J Clin Invest; 2006 Jun; 116(6):1582-95. PubMed ID: 16710476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic alterations in the RAS/RAF/mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways in the follicular variant of papillary thyroid carcinoma.
    Santarpia L; Myers JN; Sherman SI; Trimarchi F; Clayman GL; El-Naggar AK
    Cancer; 2010 Jun; 116(12):2974-83. PubMed ID: 20564403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Array-based comparative genomic hybridization reveals recurrent chromosomal aberrations and Jab1 as a potential target for 8q gain in hepatocellular carcinoma.
    Patil MA; Gütgemann I; Zhang J; Ho C; Cheung ST; Ginzinger D; Li R; Dykema KJ; So S; Fan ST; Kakar S; Furge KA; Büttner R; Chen X
    Carcinogenesis; 2005 Dec; 26(12):2050-7. PubMed ID: 16000397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional profiling of pure fibrolamellar hepatocellular carcinoma reveals an endocrine signature.
    Malouf GG; Job S; Paradis V; Fabre M; Brugières L; Saintigny P; Vescovo L; Belghiti J; Branchereau S; Faivre S; de Reyniès A; Raymond E
    Hepatology; 2014 Jun; 59(6):2228-37. PubMed ID: 24443104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphatidylinositol 3-kinase and Ras/mitogen-activated protein kinase signaling pathways are required for the regulation of 5-aminolevulinate synthase gene expression by insulin.
    Scassa ME; Guberman AS; Varone CL; Cánepa ET
    Exp Cell Res; 2001 Dec; 271(2):201-13. PubMed ID: 11716532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitogen-activated protein kinase pathway is pivotal for anoikis resistance in metastatic hepatoma cells.
    Cao L; Zhang Z; Han L; Du J; Liang X; Liu Y; Sun W
    Mol Med Rep; 2014 Apr; 9(4):1121-7. PubMed ID: 24535322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detailed genomic mapping and expression analyses of 12p amplifications in pancreatic carcinomas reveal a 3.5-Mb target region for amplification.
    Heidenblad M; Jonson T; Mahlamäki EH; Gorunova L; Karhu R; Johansson B; Höglund M
    Genes Chromosomes Cancer; 2002 Jun; 34(2):211-23. PubMed ID: 11979555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein kinase C alpha trigger Ras and Raf-independent MEK/ERK activation for TPA-induced growth inhibition of human hepatoma cell HepG2.
    Wen-Sheng W
    Cancer Lett; 2006 Jul; 239(1):27-35. PubMed ID: 16169661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Met proto-oncogene and insulin-like growth factor binding protein 3 overexpression correlates with metastatic ability in well-differentiated pancreatic endocrine neoplasms.
    Hansel DE; Rahman A; House M; Ashfaq R; Berg K; Yeo CJ; Maitra A
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6152-8. PubMed ID: 15448002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C1GALT1 enhances proliferation of hepatocellular carcinoma cells via modulating MET glycosylation and dimerization.
    Wu YM; Liu CH; Huang MJ; Lai HS; Lee PH; Hu RH; Huang MC
    Cancer Res; 2013 Sep; 73(17):5580-90. PubMed ID: 23832667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of gene expression of ATP-binding cassette protein and tyrosine kinase signaling pathway in patients with hepatocellular carcinoma.
    Hoffmann K; Shibo L; Xiao Z; Longerich T; Büchler MW; Schemmer P
    Anticancer Res; 2011 Nov; 31(11):3883-90. PubMed ID: 22110214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular carcinoma-derived exosomes promote motility of immortalized hepatocyte through transfer of oncogenic proteins and RNAs.
    He M; Qin H; Poon TC; Sze SC; Ding X; Co NN; Ngai SM; Chan TF; Wong N
    Carcinogenesis; 2015 Sep; 36(9):1008-18. PubMed ID: 26054723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hotspots of Aberrant Enhancer Activity in Fibrolamellar Carcinoma Reveal Candidate Oncogenic Pathways and Therapeutic Vulnerabilities.
    Dinh TA; Sritharan R; Smith FD; Francisco AB; Ma RK; Bunaciu RP; Kanke M; Danko CG; Massa AP; Scott JD; Sethupathy P
    Cell Rep; 2020 Apr; 31(2):107509. PubMed ID: 32294439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma.
    Zhou SL; Dai Z; Zhou ZJ; Wang XY; Yang GH; Wang Z; Huang XW; Fan J; Zhou J
    Hepatology; 2012 Dec; 56(6):2242-54. PubMed ID: 22711685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathologic significance and function of S-phase kinase-associated protein 2 overexpression in hepatocellular carcinoma.
    Zhang SH; Qian YM; Liu AW; Cai J; Zhao XL; Wei JJ; Zhu MH
    Hum Pathol; 2012 Jul; 43(7):1084-93. PubMed ID: 22204716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray.
    Li Y; Tang Y; Ye L; Liu B; Liu K; Chen J; Xue Q
    J Cancer Res Clin Oncol; 2003 Jan; 129(1):43-51. PubMed ID: 12618900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.